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A Novel Penile Splint as Early Traction Therapy After Grafting 
Techniques for Peyronie’s Disease 
ABSTRACT 
Background: Some studies showed encouraging results on the efficacy and safety of penile traction 
therapy (PTT) after Peyronie’s disease (PD) surgery. The early traction therapy (ETT) could be an 
effective and safe approach to minimize penile shortening in patients undergoing PD surgery. 
Aim: To evaluate the feasibility, efficacy, and safety of a novel penile splint as ETT in PD patients 
undergoing grafting techniques. 
Methods: PD patients underwent plaque incision and grafting (PIG) technique, at the end of the 
procedure a novel penile splint (ETT) was applied to all patient. The device consisted of two 10Ch 
intubating stylets, self-adapted to each patient, that kept the penis stretched with the aid of non-
absorbable sutures. The total expense for the materials needed to build each penile splint was less than 
15 euros. This active traction was maintained for 1-3weeks, then we removed the stitches leaving the 
device on-site for a passive traction. Within 3-4 weeks from surgery, the penile splint was replaced by 
a standard penile traction device. 
Outcomes: The main outcomes evaluated at 6 months included stretched penile length (SPL), penile 
curvature, International Index of Erectile Function - Erectile Function domain (IIEF-EF), patient 
satisfaction, and time to first satisfactory sexual intercourse. 
Results: A total of 46 patients were enrolled. The median preoperative IIEF-EF, penile curvature, and 
SPL were 27 points, 70 degrees, and 13 cm. The median follow-up was 15 months. The median 
postoperative IIEF-EF was 25 points (p < 0.001). The median residual penile curvature was 10 degrees 
(p < 0.001). The median postoperative SPL was 13 cm (p = 0.269). Eight patients (17.4%) lose 1 cm of 
SPL, no shortening greater than 1 cm was recorded. The median time to first satisfactory sexual 
intercourse and patient satisfaction score was 6 weeks and 9 points, respectively. 
Clinical Implications: Our results could pave the way for a new line of research, which in turn could 
lead to an improvement in the postoperative management of the patient undergoing surgery for PD. 
Strength & Limitations: This is the first study evaluating the ETT after PD surgery. The main 
limitation of this study is the lack of a randomized control group. Other weaknesses are the small sample 
size and the short follow-up time. 
Conclusion: Our novel penile splint is inexpensive, easy to assemble, and adaptable to the patient. ETT 










Tunical lengthening procedures are the gold standard treatment for Peyronie's disease (PD) 
patients, in stable phase of disease, with severe curvature, short penis, or complex deformities, 
without erectile dysfunction.1 These procedures are performed on the concave side of the penis 
and consist of making an incision or partial excision of the plaque, and covering the defect with 
a graft.2 The tunical lengthening techniques aim to minimize the penile shortening, 
nevertheless, a significant reduction in length of penis was described by several authors.3,4  
The current European Association of Urology (EAU) Guidelines recommend the use of penile 
traction therapy (PTT), as conservative treatment of PD, alone or in combination with other 
procedures, although outcome data are limited.1,5 The clinical goals of PTT are to reduce 
curvature, enhance circumference, and recover lost length, causing only limited adverse events 
(AE). Several studies showed encouraging results on the efficacy and safety of PTT in both the 
acute and chronic phase of PD, as well as after PD surgery.6–8 
The penile splint is a device, generally assembled by the surgeon and applied at the end of the 
penile surgery, which aims to improve the surgical outcomes.9–13  
 
Rationale and Aim 
The early traction therapy (ETT), applied immediately at the end of the surgical procedure, 
could be an effective and safe approach to minimize penile shortening in patients undergoing 
PD surgery. The aim of the present study is to evaluate the feasibility, efficacy, and safety of a 
novel penile splint as ETT in PD patients undergoing grafting techniques. 
 
Indications for procedure 
Patients with stable PD for at least 3 months, normal erectile function with or without 
pharmacological treatment, any type of penile curvature > 60° and/or no adequate penile length 
and/or complex deformities (hourglass, hinge), undergoing grafting technique, were included 
in the study. Active infectious diseases and suspect of penile tumor were exclusion criteria. 
Calcified plaques were not an exclusion criterion. All patients in whom a reduction of the penile 
length of at least 2 cm with shortening procedures was expected were considered to have a no 
adequate penile length. 
 
Patients’ recruitment and assessment 
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Patients of the present study were recruited from February 2017 to July 2019. All subjects were 
informed about the surgical procedure and provided a written informed consent. Each patient 
enrolled underwent medical and sexual history as well as a physical examination. The short 
version of the International Index of Erectile Function for the evaluation of the erectile function 
(IIEF‐EF)14 and the Peyronie's Disease Questionnaire (PDQ)15 were self-administrated to 
patients. The penile curvature was evaluated with the Kelami method.16 The stretched penile 
length (SPL) was assessed by a urologist using a tape measure, from the base (pubo-penile 
junction) to the tip of the glans (meatus) on the dorsal aspect of the penis. The study of penile 
plaques was performed with ultrasonography by a radiologist.  
 
Statistics 
We used the median as a measure of central tendency and the interquartile range (IQR) as a 
measure of statistical dispersion. The Wilcoxon Signed-Ranks Test was used to analyze the 
data. All tests were two-sided with a significance set at p < 0.05. IBM SPSS Statistics® (IBM 
Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM 
Corp.) was used for the statistical analyses. 
 
Pre-operative preparation 
Patients were placed in supine position and washed with chlorhexidine gluconate (CHG) soap. 
Intravenous sedation with local anesthesia, as well as preoperative single-dose of cefazolin, 
were administered to all patients. 
 
Intraoperative consideration 
A Gittes test17 was performed with intracavernous saline injection to evaluate penile curvature 
degree and any other deformities. All patients underwent plaque incision and grafting (PIG) 
technique with TachoSil® (Baxter, CA, USA). In all cases the whole graft (9.5 x 4.8 cm) was 
used to cover the tunical defect. Each subject underwent circumcision, while none received the 
implantation of a penile prosthesis. All surgeries were performed by a single experienced 
surgeon in an ambulatory center. At the end of the procedures, the penile splint (ETT) was 
applied to all patient by the surgeon, adapting it based on penile size (length and girth). 
 
Penile splint: assembly and cost 
First of all, the penis was wrapped with a cotton wool roll to protect the skin from pressure 
ulcers. Then, two 10Ch intubating stylets (Shiley™/Mallinckrodt™, Medtronic, MN, USA) 
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(Figure 1) were positioned vertically and fixed to penile skin with two 1/0 polypropylene 
sutures (at 3-o’clock and 9-o’clock) (Figure 2). Lastly, an elastic bandage was applied, and the 
distal parts of the stylets were bent (Figure 3) to improve patient comfort. The assembly time 
was always less than 5 minutes. The cost of each stylet was less than 5 euros, and the total 
expense for the materials needed to build each penile splint was less than 15 euros. 
 
Post-operative management and follow-up 
Patients were discharged with penile splint in the two-three hours after the procedure, being 
instructed to maintain the device until the next revision. No antibiotic was prescribed, while 
common analgesics as needed was allowed. 
Until January 2018, we maintained the active traction (device with stitches) for 2-3 weeks, 
subsequently, due to observed discomfort and pain of the patients, we reduced this time to 7 
days. Once these first days of active traction were over, we removed the stitches leaving the 
device on-site (passive traction) until 3-4 weeks after surgery. Wound cleaning and dressing 
changes were performed every 7 days. In all patients, after this period, when the circumcision 
was healed, the penile splint was replaced by a standard penile traction device 
(Andropeyronie®/Andropenis®, Andromedical SL, Madrid, Spain) for at least 4-6 months with 
intensive daily use (at least 3 hours a day).  
After 6 months from surgery, changes in penile curvature, SPL, and IIEF-EF, as well as time 
to first satisfactory sexual intercourse and patient satisfaction on a scale of 0 to 10,18 were 
assessed. All observed AE during the study period were recorded. 
 
Outcomes and Complications 
A total of 46 patients, with a median (IQR) age of 55 (45.5-61.3) years, were enrolled in the 
study. The median (IQR) preoperative IIEF-EF, penile curvature, and SPL were 27 (24-29) 
points, 70 (60-81.3) degrees, and 13 (12-15) cm, respectively. Only 3 patients (6.5%) took an 
intermediate dosage of Phosphodiesterase-5 (PDE5) inhibitors before the surgery. The baseline 
characteristics of patients are reported in Table 1.   
The median (IQR) operative time and follow-up were 80 (70-90) minutes and 15 (11.3-24) 
months, respectively. Twenty-eight patients (60.9%) used the early active traction for 7 days, 
while only 7 subjects (15.2%) for more than 2 weeks. The median (IQR) time of early active 
traction was 7 (7-14) days. 
The median (IQR) postoperative IIEF-EF was 25 (22-27) points (p < 0.001), 13 patients 
(28.3%) worsened this score and reached the minimal clinically important difference (MCID) 
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after the surgery.19 The median (IQR) residual penile curvature was 10 (5-10) degrees, with a 
statistically significant difference from the baseline (p < 0.001). Ten patients (21.7%) at 6 
months of follow-up used PDE5 inhibitors, however only 6 subjects really needed it as they 
were unable to have a satisfactory intercourse, another 4 did not want to interrupt the treatment 
because they noticed an improvement in erectile function compared to their condition before 
surgery. Eight patients (17.4%) had a residual curvature of 15 degrees, and no subject exceeded 
this value. The median (IQR) postoperative SPL was 13 (12.8-15) cm, without a significant 
difference from the baseline (p = 0.269). Only 8 patients (17.4%) lose 1 cm of SPL, no 
shortening greater than 1cm was recorded in any subject, the median difference of postsurgical-
SPL and presurgical-SPL was 0 cm. A statistically significant (p < 0.001) postoperative 
improvement of all PDQ domains was reported. The median (IQR) time to first satisfactory 
sexual intercourse and patient satisfaction score was 6 (5-8) weeks and 9 (8-9) points, 
respectively. Patients did not report any changes between the 6-month visit and the end of the 
follow-up. The postoperative outcomes are reported in Table 2. No intraoperative 
complications occurred. Five cases (10.9%) of postoperative hematoma and 2 cases (4.3%) of 
glans numbness at 6-months follow-up visit was recorded. No severe complications (Clavien-
Dindo III-V)20 were revealed, in particular, only grade I adverse events occurred during the 
study. There was no fall or movement of the dressing that required its repositioning, this was 
favored in the first weeks by the presence of the sutures that fixed the entire device to the penile 
skin. Only 3 patients (6.5%) required removal of the bandage due to excessive compression, 
however the penile splint was maintained by replacing only the dressing. 
 
Brief Literature Review and Discussion of Results 
Currently, there are no studies investigating assessing the ETT after PD surgery, as well as 
there are no papers evaluating the use of a penile splint as traction therapy in PD setting. 
Only two articles investigated the role of PTT after PD surgery,21,22 however, in both studies 
the traction was not applied immediately after the end of the surgery, but several weeks later. 
Moncada-Iribarren et al.21 reported the use of a traction device (Andropenis®, Andromedical 
SL, Madrid, Spain) after penile grafting or plication. PTT was applied when the circumcision 
had healed (2 to 3 weeks after surgery), 8 to 12 hours daily during at least 4 months. A total of 
40 men who had PD surgery (12 men with penile grafting and 28 men with penile plication) 
were randomized (20:20) to PTT vs observation. Globally, penile shortening after surgery 
ranged from 0.5 to 4.0 cm. SPL of the patients in the PTT group increased ranging from 1 to 3 
cm, and the increase was proportional to the number of hours per month of PTT use. 
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Rybak et al.22 reported in a nonrandomized retrospective study the use of a traction device 
(USPhysioMED Penile Extender®, USPhysioMED, Aliso Viejo, CA, USA) after penile 
plication or partial plaque excision and grafting. PTT was recommended for 2–6 hours a day 
for 3 months, typically starting 3–4 weeks postoperatively. In total 27/52 plication patients and 
36/59 PEG patients performed PTT. Patients who performed PTT had a significantly greater 
mean increase in SPL (compared with preoperative measurements) compared to the patient 
without traction. This was true for both the plication group (+0.85 cm vs −0.53 cm; p < 0.001) 
and the graft group (+1.48 cm vs +0.24 cm; p < 0.001). 
Several studies evaluated the use of penile splints in the last few decades.9–13 These devices 
were built by the surgeon and applied at the end of the surgical procedure. They were generally 
real craft products assembled with easily available materials such as plastic bottles, thermocol 
glasses, plastic syringes, or gauzes.10–13 The purpose of penile splints was to achieve a 
compressive effect, or keep the penis in a specific position or stretched, in order to reduce 
edema or improve the wound healing after surgery.9,11,13 Despite the abundance of studies on 
the topic present in the literature, the overall quality of them is low due to major methodological 
issues, including the lack of use of standardized outcome measures, with results reported in 
qualitative rather than quantitative form. 
The penile shortening described in other PIG series reflects, in most cases, the occurrence of a 
graft contraction.23–29 In a recent review of Rice et al.4 was reported that between 4.9% and 
40.0% of patients experienced shortening of penis after PIG. The use of our novel penile splint 
seems to prevent the graft shrinkage during the initial healing phase, and subsequent standard 
traction therapy strengthens the graft stretching, this could favor the preservation of the penile 
length after surgery. On the other hand, the low incidence of hematomas in our study, probably 
due to the maintenance of the bandage for a longer period of time, could promote the early 
recovery of sexual activity. 
 
Strength and Limitations of Our Results 
Despite abundant literature on PTT in PD patients, this is the first study evaluating the 
feasibility, efficacy, and safety of ETT after PD surgery. Our encouraging results could pave 
the way for a new line of research regarding this topic, which in turn could lead to an 
improvement in the postoperative management of the patient undergoing surgery for PD. 
The main limitation of this study is the lack of a randomized control group. Other weaknesses 




ETT using our novel penile splint, followed by standard traction therapy, seems to be feasible, 
effective, and safe. The device is inexpensive, easy to assemble, and adaptable to the patient. 
No significant penile shortening, an early recovery of satisfactory sexual activity, as well as no 
severe AE, can be obtained with its use. However, randomized controlled trials, with large 
sample size and long follow-up, are needed to confirm these preliminary results and to define 
the most appropriate duration of early traction. 
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Table 1. Baseline characteristics of patients 












o Dorsal, n (%) 
o Lateral, n (%) 
o Dorsolateral, n (%) 
o Ventral, n (%) 
 
• Complex deformities 
o Hourglass, n (%) 














IQR: interquartile range. 
 
 
Table 2. Postoperative outcomes 
 Baseline At 6 months 
from surgery 
p 




10 (5-10) < 0.001 
SPL, cm 
median (IQR) 
13 (12-15) 13 (12.8-15) 0.269 




• PDQ-SB, points 
median (IQR) 
 
• PDQ-PP, points 
median (IQR) 
 


























Patient satisfaction, points 
median (IQR) 
NA 9 (8-9) NA 
Time to first satisfactory 
sexual intercourse, weeks 
median (IQR) 
NA 6 (5-8) NA 
SPL: stretched penile length; IIEF-EF: International Index of Erectile Function - Erectile 
Function domain; PDQ: Peyronie's Disease Questionnaire; PDQ-SB: PDQ-Symptom Bother; 
PDQ-PP: PDQ-Penile Pain; PDQ-PS: PDQ-Psychological and Physical Symptoms; IQR: 
interquartile range; NA: Not Available. 
 
Figures 





Figure 2. Assembly of the penile splint 
 
 
Figure 3. Aspect of the assembled penile splint 
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